Shilpa Medicare (NSE:SHILPAMED) Cyclically Adjusted Revenue per Share: ₹72.70 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SHILPAMED Shilpa Medicare Ltd NSE:SHILPAMED
76 GF Score
Price ₹606.20
GF Value ₹388.40
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Shilpa Medicare Cyclically Adjusted Revenue per Share?

Shilpa Medicare NSE:SHILPAMED +0.43% 76 Cyclically Adjusted Revenue per Share is ₹72.70 as of Mar. 2026. GuruFocus rates NSE:SHILPAMED with a GF Score™ of 76/100 and a GF Value™ of ₹388.40 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Shilpa Medicare's adjusted revenue per share for the three months ended in Mar. 2026 was ₹22.338. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹72.70 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shilpa Medicare's average Cyclically Adjusted Revenue Growth Rate was 4.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 6.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Shilpa Medicare was 8.50% per year. The lowest was 4.50% per year. And the median was 7.00% per year.

As of today (2026-07-26), Shilpa Medicare's current stock price is ₹606.20. Shilpa Medicare's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ₹72.70. Shilpa Medicare's Cyclically Adjusted PS Ratio of today is 8.34.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shilpa Medicare was 8.63. The lowest was 1.80. And the median was 4.36.


Shilpa Medicare  (NSE:SHILPAMED) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Shilpa Medicare's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=606.20/72.70
=8.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shilpa Medicare was 8.63. The lowest was 1.80. And the median was 4.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Shilpa Medicare Cyclically Adjusted Revenue per Share Related Terms


Shilpa Medicare Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Shilpa Medicare's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shilpa Medicare Cyclically Adjusted Revenue per Share Chart

Shilpa Medicare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 58.72 63.48 66.83 69.33 72.70

Shilpa Medicare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.33 71.01 71.41 72.08 72.70

NSE:SHILPAMED vs ZTS, UTHR: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shilpa Medicare's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shilpa Medicare Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shilpa Medicare's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shilpa Medicare's Cyclically Adjusted PS Ratio falls into.


NSE:SHILPAMED
76GF Score
Shilpa Medicare Ltd NSE:SHILPAMED
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shilpa Medicare Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shilpa Medicare's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=22.338/164.2724*164.2724
=22.338

Current CPI (Mar. 2026) = 164.2724.

Shilpa Medicare Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 10.832 105.961 16.793
201609 14.079 105.961 21.827
201612 11.092 105.196 17.321
201703 13.291 105.196 20.755
201706 10.363 107.109 15.894
201709 12.575 109.021 18.948
201712 11.378 109.404 17.084
201803 15.209 109.786 22.757
201806 12.164 111.317 17.951
201809 9.944 115.142 14.187
201812 10.637 115.142 15.176
201903 9.515 118.202 13.224
201906 9.868 120.880 13.410
201909 17.786 123.175 23.720
201912 14.518 126.235 18.893
202003 12.955 124.705 17.065
202006 13.672 127.000 17.684
202009 17.119 130.118 21.613
202012 11.722 130.889 14.712
202103 12.710 131.771 15.845
202106 14.199 134.084 17.396
202109 18.121 135.847 21.913
202112 16.084 138.161 19.124
202203 19.358 138.822 22.907
202206 15.389 142.347 17.759
202209 15.144 144.661 17.197
202212 15.068 145.763 16.981
202303 14.876 146.865 16.639
202306 15.446 150.280 16.884
202309 18.448 151.492 20.004
202312 16.590 152.924 17.821
202403 16.711 153.035 17.938
202406 15.185 155.789 16.012
202409 17.578 157.882 18.289
202412 16.375 158.323 16.990
202503 16.872 157.552 17.592
202506 16.421 159.755 16.885
202509 18.916 162.289 19.147
202512 21.689 163.281 21.821
202603 22.338 164.272 22.338

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹72.70 mean?
Shilpa Medicare (NSE:SHILPAMED) has a Cyclically Adjusted Revenue per Share of ₹72.70 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Shilpa Medicare and its competitors.
Is Shilpa Medicare's Cyclically Adjusted Revenue per Share too high?
Shilpa Medicare's current Cyclically Adjusted Revenue per Share is ₹72.70. Overall, Shilpa Medicare has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shilpa Medicare's Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
Shilpa Medicare's Cyclically Adjusted Revenue per Share of ₹72.70 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Shilpa Medicare and its competitors. Shilpa Medicare's current Cyclically Adjusted Revenue per Share is ₹72.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shilpa Medicare stock overvalued right now?
Based on GuruFocus' analysis, Shilpa Medicare (NSE:SHILPAMED) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹388.40, compared to a current price of ₹606.20 — trading 56.1% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹72.70. Shilpa Medicare's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Shilpa Medicare (NSE:SHILPAMED), the current Cyclically Adjusted Revenue per Share is ₹72.70 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shilpa Medicare (NSE:SHILPAMED) Overvalued in 2026?

Based on GuruFocus' analysis, Shilpa Medicare stock appears to be overvalued. The current stock price of ₹606.20 is trading 56.1% above its estimated GF Value™ of ₹388.40. GuruFocus considers Shilpa Medicare to be Significantly Overvalued.

Key valuation signals for NSE:SHILPAMED:

  • Cyclically Adjusted Revenue per Share: ₹72.70
  • GF Value™: ₹388.40 vs. price of ₹606.20 (56.1% above fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the NSE:SHILPAMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shilpa Medicare Business Description

Other Exchanges 530549:India
Address Hyderabad Road, No. 12-6-214/A-1, Shilpa House, Raichur, KA, IND, 584135
Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company deals in high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, Formulations, New Drug Delivery Systems, Peptides, Biotech products, and Specialty Chemicals etc. Its portfolio comprises various oncology and non-oncology-related APIs such as anastrozole, acebrophylline, busulphan, decitabine, etc, and finished dosage formulations such as apremilast tablets, clofarabine injection, docetaxel injection, etc., in various therapy areas. Its reporting segments are: Pharmaceutical product and services, which derive maximum revenue, Power sales, and Others. Geographically, the company generates maximum revenue from India, followed by Europe, the United States of America, and the Rest of the world.
76GF Score

Get the complete analysis for NSE:SHILPAMED

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹606.20
Price
₹388.40
GF Value